Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Professor: CIBB Chair in Cellular and Molecular Biology

Total project amount

123,39 thousand €

Amount paid

0 €

Non-refundable funding

123,39 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.15623.TENURE.091

Summary

Scientific profile and tasks to be assigned :The Assistant Professor to be hired will be a versatile cellular and molecular biologist engaged in cutting-edge research and with a focus on Neuroscience, Metabolism, Infection, Immunology, Cardiology, Cancer or the development of Advanced Therapies (regenerative, gene-based, etc). The successful candidate must show proven ability to integrate advanced molecular techniques (e.g. genetic models, CRISPR-Cas9 gene editing, single cell analysis, high-throughput omics), innovative cellular models (e.g. advanced cell culture systems; human-derived cells or organoid systems, differentiated from induced pluripotent stem cells), and sophisticated functional readouts (e.g. advanced imaging, biophysical methods, etc) to unravel complex biological mechanisms. The scientist to be hired must show capacity to secure funding to support research, and to promote a dynamic research line, contributing to innovative projects. International collaborations with clinicians, geneticists, bioinformaticians and other researchers with complementary expertise will be appreciated. Rationale for the need, relevance of the scientific profile in the context of the state-of-the-art and involved institutions :The overarching commitment of CIBB researchers is to i) advancing knowledge in Metabolism, Neuroscience, Infection and Ageing, ii) characterizing mechanisms of disease and identifying new therapeutic targets, and iii) developing innovative therapies based on newly identified therapeutic targets and ingenious technological approaches. The need of a Cellular and Molecular Biology position is justified by the significant advances in the last decade in i) gene editing technologies, such as the CRISPR-Cas9 technology and others, that allow gene manipulation and generation of sophisticated genetic models; ii) high-throughput omics technologies (genomics, transcriptomics, proteomics, metabolomics), and in the development of bioinformatics tools for data analysis; iii) single cell analysis and spatial transcriptomics, which provide insight into cellular heterogeneity; iv) understanding organelle biology, with implications in aging and diseases; v) advanced methods (imaging, biophysical, others) to measure physiological outcomes; vi) stem cell biology and regenerative medicine, allowing the use of human models, including induced pluripotent stem cells, organoid culture systems, and the differentiation of stem cells into specific cell types. These advances will propel research in the biomedical field in the decade to come, justifying the investment of CIBB in a molecular and cellular biologist with this type of know-how, who can contribute to the thematic lines at CIBB.Cellular and Molecular Biology is one of the scientific areas of the Faculty of Sciences and Technology of the University of Coimbra, through its Life Sciences Department. With the appointment of an Assistant Professor in Cellular and Molecular Biology, the department will strengthen this scientific area through fostering research that is driven by the application of a combination of state-of-the art molecular approaches with advanced cellular systems and sophisticated functional readouts. The combination of these approaches represents the forefront of discovery in scientific areas that are crucial for the Faculty of Sciences and Technology, which will leverage the expertise of such a researcher not only to advance research but also to mentor and train the next generation of biochemists and biologists.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,3
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

123,39 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Coimbra 123,39 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading